Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Actavis bolsters infectious disease portfolio with Durata purchase

Authored by James Sheppard The global generics giant Actavis has announced a deal to acquire the Chicago based infectious disease specialist Durata Therapeutics. The deal is estimated to be worth in excess of $675m. The deal will see Actavis paying … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , | Leave a comment

Celgene and BMS team up for cancer immunotherapy development

Authored by James Sheppard The two global biopharma giants, Celgene and BMS, have announced a collaboration to advance cancer immunotherapies across multiple tumour types. The partnership will see the two companies study a combination of BMS’s anti-PD-1 drug Opdivo (nivolumab) … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment

Rare Disease Biotech Summit plc Appoints Erik Ostrowski as CFO

Authored by James Sheppard The Oxford Biotech cluster based rare disease biotech Summit plc has announced the appointment of a new Chief Financial Officer (CFO). Summit announced that Mr Erik Ostrowski will join the company as CFO with immediate effect … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business, Recruitment Market | Tagged , , , , , , , , , , , , | Leave a comment

Wilson Therapeutics Raises $40m to advance development program

Authored by James Sheppard The Stockholm based rare disease biotech, Wilson Therapeutics, announced that it had raises $40m in series B funding. The funding was co-led by new investors Abingworth LLP and MVM Life Science Partners LLP. The new investors … Continue reading

Posted in Executive Appointments, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Minoryx gains Orphan Drug Designation in X-Linked Adrenoleukodystrophy

Authored by Karl Simpson Nestled in the Bio-Cat cluster in Barcelona, Spain is the orphan drug therapeutics company, Minoryx Therapeutics, which is developing new medicines for the treatment of inborn errors in metabolism. The company is addressing these particular rare … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , | 1 Comment

Biosimilars – is global development a reality?

Dr Narayanan is the Managing Director of Biologicals Advice Limited. He offers independent advice on all aspects of medicine development with special expertise on biologicals, advanced therapies and biosimilars. He qualified as a medical doctor and subsequently obtained post-graduate qualifications in … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Dr Francois Nader – NPS Pharmaceuticals – Executive Leadership Series

Authored by Karl Simpson At the beginning of 2013 Liftstream profiled 13 life science leaders we believed were going to make an impact over the course of the year. Below we outline how Dr Francois Nader performed for NPS Pharmaceuticals in 2013. 2013 Liftstream … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , | Leave a comment

Dr John Martin – Gilead – Executive Leadership Series

Authored by James Sheppard At the beginning of 2013 Liftstream profiled 13 life science leaders we believed were going to make an impact over the course of the year. Below we outline how Dr John Martin performed for Gilead in 2013. 2013 Liftstream Analysis: Gilead Sciences … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment

PTC Therapeutics appoints Chief Medical Officer and communicates CHMP conditional decision

Authored by Karl Simpson For patients living with Duchenne Muscular Dystrophy, last year offered great hope but also disappointment. The momentum was building in the development of exciting new therapies and they were looking forward to the promise of meaningful … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Jazz Pharmaceuticals to acquire rare disease company Gentium

Authored by James Sheppard Jazz Pharmaceuticals, based in Dublin, Ireland, recently announced that it had acquired Italian based rare disease drug company Gentium in a $1bn deal. The deal will give Jazz access to Gentium’s 3 marketed products and extensive … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , | 2 Comments




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap